MDH1 and rheumatoid arthritis: As MDH1 is considered a linkage between glycolysis and TCA cycle, inhibition of MDH1 is considered a promising target for the suppression of the glycolytic pathway, TCA cycle, T cell differentiation and decreasing the inflammatory milieu in RA so it may be a prospective treatment target for RA disease.